Features
Pricing
Newsletter
Events
Partners
Features
Pricing
Newsletter
Events
Partners
Loading organizations...
QVT: Funding, Team & Investors | Startup Intros
Home
/
Organizations
/
QVT
QVT
Active
Website
LinkedIn
Follow
Copy .md
Share
Post on X
Post on LinkedIn
Share on Reddit
Share on WhatsApp
Share on Telegram
Send an Email
Updated:
Apr 2, 2026
·
Suggest an edit
About
News
Financials
Team
Deep Dive
FAQs
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at QVT.
LE
Lars E. Bader
Portfolio Manager
TF
Tracy Fu
Managing Partner
DC
Dan Collins
Partner & Chief Operating Officer
NB
Nicholas Brumm
Managing Director
DA
Daniel A. Gold
Managing Partner and CEO
Leadership Team
Key people at QVT.
LE
Lars E. Bader
Portfolio Manager
TF
Tracy Fu
Managing Partner
DC
Dan Collins
Partner & Chief Operating Officer
NB
Nicholas Brumm
Managing Director
Daniel A. Gold
Managing Partner and CEO
Financial History
Total Raised
N/A
Valuation
N/A
Investments Made
Date
Company
Round
Lead Investor(s)
Co-Investor(s)
Dec 18, 2025
Syremis Therapeutics
$165.0M Series A
Uri Oren
, Reid Huber
Google Ventures
, Raymond Sanchez, M.D.
,
Pictet Alternative Advisors
May 13, 2024
Active Surfaces
$5.6M Pre-Seed
Safar Partners
Lendlease
,
New Climate Ventures
,
Sabanci Climate Ventures
,
SeaX Ventures
,
Type One Ventures
,
Umami Capital
May 16, 2022
Kriya Therapeutics
$270.0M Series C
Jim Momtazee
Bluebird Ventures
,
CAM Capital
,
Dexcel Pharma
,
Foresite Capital
, JDRF T1D Fund
,
Lightswitch Capital
,
Narya Capital
,
Transhuman Capital
Jul 14, 2021
Kriya Therapeutics
$100.0M Series B
Jim Momtazee
Alumni Ventures
,
Amplo
,
Bluebird Ventures
,
CAM Capital
,
Dexcel Pharma
,
Foresite Capital
,
Hongkou
, JDRF
,
Narya Capital
,
Transhuman Capital
,
Woodline Partners
Sep 1, 2015
AveXis
$65.0M Series D
Taymour Tamaddon
Atlas Venture
,
Deerfield Management
,
Hatteras Venture Partners
,
Omega Funds
,
RA Capital
,
Roche Venture Fund
, Jonathan Root
,
Adage Capital Management
,
Boxer Capital
,
Foresite Capital
, Janus Henderson Investors
, RA Capital Management
, Roche
,
Rock Springs Capital
,
RTW Investments
,
Venrock
May 1, 2015
REGENXBIO
$71.0M Series D
Venrock
,
Vivo Capital
,
Brookside Capital
ARCH Venture Partners
,
Canaan Partners
,
Cormorant Asset Management
,
Deerfield Management
,
Foresite Capital
, F-Prime Capital
, Janus Henderson Investors
,
Jennison Associates
,
Perceptive Advisors
,
RTW Investments
,
Sectoral Asset Management
,
Tourbillon Global Ventures